請更新您的瀏覽器
您使用的瀏覽器版本較舊,已不再受支援。建議您更新瀏覽器版本,以獲得最佳使用體驗。
啟用Javascript
請在瀏覽器上啟用JavaScript來瀏覽頁面中的所有內容。
登入
Everest Medicines Announces NEFECON® Has Received Full Approval from South Korea's Ministry of Food and Drug Safety (MFDS) for the Treatment of Primary IgA Nephropathy
PR Newswire (美通社)
傳送
熱門
最多關注
最新
沒有留言。
Everest Medicines Announces NEFECON® Has Received Full Approval from South Korea's Ministry of Food and Drug Safety (MFDS) for the Treatment of Primary IgA Nephropathy